- Home
- ALGS vs CLPR Comparison
ALGS vs CLPR Comparison
Compare ALGS & CLPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ALGS | CLPR |
|---|---|---|
| Founded | 2018 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 57.2M | 54.6M |
| IPO Year | 2020 | 2017 |
Fundamental Metrics
Financial Performance| Metric | ALGS | CLPR |
|---|---|---|
| Price | $11.14 | $3.42 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $60.00 | N/A |
| AVG Volume (30 Days) | ★ 81.5K | 70.1K |
| Earning Date | 11-06-2025 | 11-13-2025 |
| Dividend Yield | N/A | ★ 11.21% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $2,646,000.00 | ★ $154,179,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 5.90 |
| 52 Week Low | $3.76 | $3.37 |
| 52 Week High | $46.80 | $6.49 |
Technical Indicators
Market Signals| Indicator | ALGS | CLPR |
|---|---|---|
| Relative Strength Index (RSI) | 60.44 | 39.81 |
| Support Level | $9.10 | $3.39 |
| Resistance Level | $13.69 | $3.50 |
| Average True Range (ATR) | 0.87 | 0.11 |
| MACD | 0.24 | -0.00 |
| Stochastic Oscillator | 50.23 | 11.90 |
Price Performance
Historical ComparisonAbout ALGS Aligos Therapeutics Inc.
Aligos Therapeutics Inc is a clinical stage biopharmaceutical company. It is engaged in developing novel therapeutics to address unmet medical needs in viral and liver diseases, including chronic hepatitis B and coronaviruses, and therapeutics for nonalcoholic steatohepatitis (NASH). The company's pipeline includes ALG-010133, ALG-000184, ALG-020572 and ALG-055009, among others.
About CLPR Clipper Realty Inc.
Clipper Realty Inc is a self-administered and self-managed real estate company. It acquires, owns, manages, operates, and repositions multifamily residential and commercial properties in the New York metropolitan area, with a portfolio in Manhattan and Brooklyn. It has classified its reporting segments into Residential Rental Properties and Commercial Rental Properties. The company derives its revenue mostly from the Residential segment.